THNR ETF: Amplify Weight Loss Drug & Treatment ETF - Price, Holdings & Analysis
Amplify Weight Loss Drug & Treatment ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About Amplify Weight Loss Drug & Treatment ETF
What is the current price of THNR?
The latest THNR price is $26.43. The 52-week range is $21.96–$27.28. THNR has returned 20.6% over the past 52 weeks.
What is the expense ratio for THNR?
THNR's annual expense ratio is 0.59%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does THNR pay dividends?
Yes, THNR pays a 1.56% dividend yield. The last ex-dividend date was 2026-12-31. View full dividend history in the Dividends section.
What are the top holdings of THNR?
THNR's largest holdings are Novo Nordisk A/S (10.2%), Eli Lilly and Company (9.2%), Innovent Biologics Inc (5.7%) (combined weight: 25.1%). The fund holds 23 total positions. View the complete portfolio breakdown in the Holdings section.
How does THNR compare to similar ETFs?
Compare THNR (0.59% expense ratio, $5M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.